Cargando…
Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor and a subpopulation of glioma stem-like cells (GSCs) is likely responsible for the invariable recurrence following maximum resection and chemoradiotherapy. As most GSCs that are located in the perivascular and perinecrotic ni...
Autores principales: | Nishikawa, Masahiro, Inoue, Akihiro, Ohnishi, Takanori, Kohno, Shohei, Ohue, Shiro, Matsumoto, Shirabe, Suehiro, Satoshi, Yamashita, Daisuke, Ozaki, Saya, Watanabe, Hideaki, Yano, Hajime, Takahashi, Hisaaki, Kitazawa, Riko, Tanaka, Junya, Kunieda, Takeharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126065/ https://www.ncbi.nlm.nih.gov/pubmed/30210550 http://dx.doi.org/10.1155/2018/5387041 |
Ejemplares similares
-
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021) -
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021) -
CBMS-04 SIGNIFICANT ROLE OF HYPOXIA IN THE EXPRESSION AND FUNCTION OF OSTEOPONTIN IN CD44-HIGHLY EXPRESSED GLIOMA STEM-LIKE CELLS IN TUMOR PROGRESSION OF GLIOBLASTOMA
por: Nishikawa, Masahiro, et al.
Publicado: (2019) -
COT-3 Exosomal microRNA expression signature in blood and cerebrospinal fluid of glioblastoma patients
por: Yamashita, Daisuke, et al.
Publicado: (2021) -
Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence
por: Inoue, Akihiro, et al.
Publicado: (2023)